Gujarat Themis Biosyn Limited (GUJTHEM) — Announcement | 26 June 2026

StockFin.ai

Try Free

Gujarat Themis Biosyn Limited disclosed that it has initiated arbitration against Optimus Drugs Private Limited for breaching a supply agreement, seeking recovery of Rs. 75 crore in break fees, Rs. 23.8 lakh in delayed payment interest, and Rs. 15 crore in damages, while stating no financial penalty is expected.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GUJTHEM ✨ Ask AI About This

About Gujarat Themis Biosyn Limited (GUJTHEM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,034.98 Cr P/E: 84.4

View full GUJTHEM stock details →

📡 Get AI alerts when GUJTHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GUJTHEM — Free

💡 Ask AI about this filing

"How does this announcement affect Gujarat Themis Biosyn Limited's outlook?" "What did Gujarat Themis Biosyn Limited announce on 26 June 2026?" "Is this positive or negative for GUJTHEM?"

Ask AI Free →

📊 More GUJTHEM filings

See all GUJTHEM filings →

🔥 Also filed on 26 June 2026

SAPPHIRE Sapphire Foods India Limited Annual Report PURVA Puravankara Limited Announcement PRIMO Primo Chemicals Limited Announcement RAJSREESUG Rajshree Sugars & Chemicals Limited Annual Report RAJESHEXPO Rajesh Exports Limited Announcement SAPPHIRE Sapphire Foods India Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when GUJTHEM files new disclosures

Track GUJTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GUJTHEM — Free

Free account · 2 AI queries/day